Structure-Activity Relationships and Drug Design
Drug Discovery: Overview
Pharmacogenomics: Identification of New Drug Targets
Phylogenetic Trees
Quantitative Aspects of Drug-Receptor Interaction
Methods of Medium Optimization
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 28, 2026

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
Published on: July 25, 2013
Maksym Druchok1,2, Andrij Rovenchak1,3
1SoftServe, Inc., 2d Sadova Street, 79021 Lviv, Ukraine.
This study introduces a computational framework for de novo drug design, optimizing molecules against orexin and histamine receptors. The approach efficiently navigates chemical space for selective or multitarget inhibitors with desirable properties.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: